KR20240144143A - 응고된 혈액 덩어리를 제조하기 위한 응고 몰드, 키트 및 방법 - Google Patents

응고된 혈액 덩어리를 제조하기 위한 응고 몰드, 키트 및 방법 Download PDF

Info

Publication number
KR20240144143A
KR20240144143A KR1020247024731A KR20247024731A KR20240144143A KR 20240144143 A KR20240144143 A KR 20240144143A KR 1020247024731 A KR1020247024731 A KR 1020247024731A KR 20247024731 A KR20247024731 A KR 20247024731A KR 20240144143 A KR20240144143 A KR 20240144143A
Authority
KR
South Korea
Prior art keywords
powder
whole blood
calcium gluconate
size distribution
per
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020247024731A
Other languages
English (en)
Korean (ko)
Inventor
알론 쿠슈니르
Original Assignee
리드레스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 리드레스 리미티드 filed Critical 리드레스 리미티드
Publication of KR20240144143A publication Critical patent/KR20240144143A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/00987—Apparatus or processes for manufacturing non-adhesive dressings or bandages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Materials Engineering (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Manufacturing & Machinery (AREA)
  • Botany (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
KR1020247024731A 2022-01-25 2023-01-25 응고된 혈액 덩어리를 제조하기 위한 응고 몰드, 키트 및 방법 Pending KR20240144143A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL290122 2022-01-25
IL290122A IL290122B2 (en) 2022-01-25 2022-01-25 Clotting template, kit and method for making a blood clot
PCT/IL2023/050083 WO2023144818A1 (en) 2022-01-25 2023-01-25 A coagulation mold, a kit and a method for preparing a coagulated blood mass

Publications (1)

Publication Number Publication Date
KR20240144143A true KR20240144143A (ko) 2024-10-02

Family

ID=85238983

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020247024731A Pending KR20240144143A (ko) 2022-01-25 2023-01-25 응고된 혈액 덩어리를 제조하기 위한 응고 몰드, 키트 및 방법

Country Status (11)

Country Link
US (4) US12397018B2 (https=)
EP (1) EP4447889A1 (https=)
JP (1) JP2025504710A (https=)
KR (1) KR20240144143A (https=)
CN (1) CN118613239A (https=)
AU (1) AU2023214201A1 (https=)
CA (1) CA3242778A1 (https=)
IL (1) IL290122B2 (https=)
MX (1) MX2024009036A (https=)
WO (1) WO2023144818A1 (https=)
ZA (1) ZA202406452B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025243305A1 (en) 2024-05-23 2025-11-27 Reddress Ltd. Controlled drug delivery
EP4686486A1 (en) * 2024-07-30 2026-02-04 Paul Hartmann AG Gel composition comprising whole blood

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2381969T3 (en) * 2009-01-27 2016-09-05 Reddress Ltd METHODS OF MAKING wound dressings AND A BANK wound dressings
IL254636A0 (en) 2017-09-24 2017-11-30 Reddress Ltd System and method for preparing a wound dressing
IL257229B (en) 2018-01-30 2022-07-01 Reddress Ltd Blood applicator for tissue treatment

Also Published As

Publication number Publication date
CN118613239A (zh) 2024-09-06
EP4447889A1 (en) 2024-10-23
US12397018B2 (en) 2025-08-26
IL290122B2 (en) 2023-08-01
WO2023144818A1 (en) 2023-08-03
US20250161353A1 (en) 2025-05-22
AU2023214201A2 (en) 2024-08-15
MX2024009036A (es) 2024-08-06
US20250114399A1 (en) 2025-04-10
IL290122B1 (en) 2023-04-01
US20240374636A1 (en) 2024-11-14
US20250186488A1 (en) 2025-06-12
IL290122A (https=) 2022-03-01
AU2023214201A1 (en) 2024-08-08
ZA202406452B (en) 2025-04-30
JP2025504710A (ja) 2025-02-17
US12364713B2 (en) 2025-07-22
US12599629B2 (en) 2026-04-14
CA3242778A1 (en) 2023-08-03

Similar Documents

Publication Publication Date Title
KR20240144143A (ko) 응고된 혈액 덩어리를 제조하기 위한 응고 몰드, 키트 및 방법
Ginebra et al. Factors affecting the structure and properties of an injectable self‐setting calcium phosphate foam
Marras-Marquez et al. Robust and versatile pectin-based drug delivery systems
GB2260977A (en) Calcium phosphate cement compositions
Andersen et al. Ionically gelled alginate foams: Physical properties controlled by type, amount and source of gelling ions
CN109265942B (zh) 一种聚乳酸微球及其制备方法与应用
EP0166263A1 (en) Filler composition for filling in defect or hollow portion of bone and kit or set for the preparation of the filler composition
Ginebra et al. Injectable biomedical foams for bone regeneration
Vásquez et al. α-TCP cements prepared by syringe-foaming: Influence of Na2HPO4 and surfactant concentration
Pasquier et al. Injectable percutaneous bone biomaterials: an experimental study in a rabbit model
KR20150080901A (ko) 섬유소 응괴 생체 재료를 채취, 생성 및 이식하는 방법 및 장치
Flautre et al. Evaluation of hydroxyapatite powder coated with collagen as an injectable bone substitute: microscopic study in rabbit
CN106139253A (zh) 可形成复合骨水泥的组合物及由其形成的骨水泥
CN106075606B (zh) 一种锶磷灰石骨水泥及制备方法
ES2284838T3 (es) Procedimiento para la produccion de un material compuesto polimero-ceramico biocompatible con una porosidad predeterminada.
JP2917544B2 (ja) 頭蓋骨穿孔部充填材
CN105770986B (zh) 一种可注射生物钙盐复合性骨水泥及其制备方法
JP2018075361A (ja) ポリメチルメタクリレート骨セメントを製造する方法、前記方法において使用するための骨セメントキット、および前記方法によって製造することができる骨セメント
JP6807099B2 (ja) 生体活性セメントペーストおよび生体活性セメントを製造するためのキット、生体活性セメントペーストおよびその製造方法
JP2005111130A (ja) 骨補填材の製造方法
JP3561127B2 (ja) 骨修復材
CA2111697C (en) A process for producing suppositories by compression and suppositories obtained by the process
CN121175080A (zh) 骨移植组合物及其制备方法
WO2017180648A1 (en) Fibrin and/or dialdehyde starch hydrolysate materials, and preparation and use thereof
CN115970063A (zh) 一种载药聚乳酸微球复合pmma骨水泥的制备方法

Legal Events

Date Code Title Description
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000